A pilot program developed by researchers at Yale Cancer Center offering next day access for oncologic consultation for patients showed reduced wait times for initial access to cancer care and increased patient satisfaction, according to a new report.
Researchers with Memorial Sloan Kettering and City of Hope have created a tool that uses machine learning to assess a non-Hodgkin lymphoma patient’s likely response to chimeric antigen receptor T-cell therapy before starting the treatment, according to study results published on April 1 in Nature Medicine.
